This module begins by explaining the service characteristics and admission criteria for ASAM Level of Care 3.7. It then delves into the certification requirements by detailing the ASAM Level of Care standards, as well as the rating elements with which programs will be assessed. These standards and rating elements span all six service characteristic categories found in The ASAM Criteria: Setting, Support Systems, Staff, Assessment/Treatment Planning, Therapies, and Documentation. Viewers will also learn about important considerations in crafting policies and procedures that meet the certification requirements.

This free series of live and on-demand webinars occurs on the first Friday of the month and discusses addiction/toxicology cases in an interactive fashion featuring experts from addiction medicine, addiction psychiatry, and medical toxicology.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about adapting a low-threshold buprenorphine program for vulnerable populations during the COVID-19 pandemic.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about disparities in documented drug use disorders between transgender and cisgender US Veterans Health Administration patients.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about treating opioid use disorder in Puerto Rico during the COVID-19 pandemic.

This one hour on-demand journal article examines buprenorphine/naloxone for Opioid Use Disorder among Alaska Native and American Indian people.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about imaging in vaping-associated lung injury.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the associations between exposure to tobacco interventions during inpatient treatment and substance use outcomes.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the influence of an opioid use disorder on initiating physical therapy for low back pain.

This 10-hour, free series of on-demand case conferences focuses on the impact of COVID19, discusses challenging cases/opportunities given the rapidly changing landscape of treatment, and provides an overview of ASAM COVID19 resources.